Investigating the Molecular Mechanism of Xijiao Dihuang Decoction for the Treatment of SLE Based on Network Pharmacology and Molecular Docking Analysis

被引:12
作者
Wei, Fangzhi [1 ]
Song, Yitian [1 ]
Gong, Aiming [1 ]
Pan, Chengdan [1 ]
Zhuang, Yanping [1 ]
Zhang, Xuan [1 ]
Zeng, Minyu [1 ]
机构
[1] Hainan Med Univ, Dept Tradit Chinese Med, Haikou 571199, Hainan, Peoples R China
基金
美国国家科学基金会;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; CELLS; SUSCEPTIBILITY; ASSOCIATION; CYTOSCAPE; DISEASE;
D O I
10.1155/2022/5882346
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective. To elucidate the main mechanism of Xijiao Dihuang decoction (XJDHT) for the treatment of systemic lupus erythematosus (SLE). Methods. TCMSP, BATMAN-TCM, ETCM, and TCMID databases and literature search were used to screen the potential active compounds of XJDHT, and TCMSP and SwissProt databases were searched to predict the targets of the compounds. The targets of SLE were obtained from Genegards, OMIM, and DisGeNET databases, and Venn online platform was used to obtain the intersection targets of XJDHT and SLE. Afterwards, the PPI network was constructed by using the STRING database, and the core targets were identified by network topology analysis. GO and KEGG enrichment analyses were performed through R software, and molecular docking of the top three core targets and their corresponding compounds were accomplished by Autodock Vina and Pymol softwares. Results. There were 30 potential active ingredients, 289 potential targets, and 129 intersection targets screened from the above databases. Network topology analysis identified 23 core targets, such as AKT1, TNF, IL6, IL1B, and INS. GO enrichment analysis obtained 2555 terms and mainly clustering on the react to lipopolysaccharide, membrane raft, and ubiquitin-like protein ligase binding. KEGG enrichment analysis obtained 187 signaling pathways, mainly concentrating on the lipid and atherosclerosis, AGE-RAGE signaling pathway in diabetic complications, fluid shear stress, and atherosclerosis. Molecular docking verified that the active compounds of XJDHT have the strong binding activity to the core targets. Conclusion. This study preliminarily uncovers the mechanism of XJDHT acting on SLE through a "multicompound, multitarget, and multipathway" manner. XJDHT may achieve the treatment of SLE by inhibiting the proinflammatory factors, inflammatory signal cvtokines, proliferation, injury, and apoptosis processes. In summary, the present study would provide a promising theoretical basis for further clinical and experimental studies.
引用
收藏
页数:20
相关论文
共 59 条
  • [1] Al Mahmud R, 2018, METHODS MOL BIOL, V1825, P3, DOI 10.1007/978-1-4939-8639-2_1
  • [2] UniProt: the universal protein knowledgebase in 2021
    Bateman, Alex
    Martin, Maria-Jesus
    Orchard, Sandra
    Magrane, Michele
    Agivetova, Rahat
    Ahmad, Shadab
    Alpi, Emanuele
    Bowler-Barnett, Emily H.
    Britto, Ramona
    Bursteinas, Borisas
    Bye-A-Jee, Hema
    Coetzee, Ray
    Cukura, Austra
    Da Silva, Alan
    Denny, Paul
    Dogan, Tunca
    Ebenezer, ThankGod
    Fan, Jun
    Castro, Leyla Garcia
    Garmiri, Penelope
    Georghiou, George
    Gonzales, Leonardo
    Hatton-Ellis, Emma
    Hussein, Abdulrahman
    Ignatchenko, Alexandr
    Insana, Giuseppe
    Ishtiaq, Rizwan
    Jokinen, Petteri
    Joshi, Vishal
    Jyothi, Dushyanth
    Lock, Antonia
    Lopez, Rodrigo
    Luciani, Aurelien
    Luo, Jie
    Lussi, Yvonne
    Mac-Dougall, Alistair
    Madeira, Fabio
    Mahmoudy, Mahdi
    Menchi, Manuela
    Mishra, Alok
    Moulang, Katie
    Nightingale, Andrew
    Oliveira, Carla Susana
    Pundir, Sangya
    Qi, Guoying
    Raj, Shriya
    Rice, Daniel
    Lopez, Milagros Rodriguez
    Saidi, Rabie
    Sampson, Joseph
    [J]. NUCLEIC ACIDS RESEARCH, 2021, 49 (D1) : D480 - D489
  • [3] Besliu Alina Nicoleta, 2009, Roum Arch Microbiol Immunol, V68, P69
  • [4] Bitencourt-Ferreira G, 2019, METHODS MOL BIOL, V2053, P125, DOI 10.1007/978-1-4939-9752-7_9
  • [5] Increased ERK and JNK activation and decreased ERK/JNK ratio are associated with long-term organ damage in patients with systemic lupus erythematosus
    Bloch, Olga
    Amit-Vazina, Mirit
    Yona, Eli
    Molad, Yair
    Rapoport, Micha J.
    [J]. RHEUMATOLOGY, 2014, 53 (06) : 1034 - 1042
  • [6] Anti-hypertensive effects of Radix Rehmanniae and its active ingredients
    Chao, Chiu-Haw
    Hsu, Jue-Liang
    Chen, Mu-Fen
    Shih, Ya-Hu
    Lee, Chia-Hui
    Wu, Mei-Li
    Chang, Chi-, I
    [J]. NATURAL PRODUCT RESEARCH, 2020, 34 (11) : 1547 - 1552
  • [7] Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity
    Chen, Lingyan
    Wang, Yong-Fei
    Liu, Lu
    Bielowka, Adrianna
    Ahmed, Rahell
    Zhang, Huoru
    Tombleson, Phil
    Roberts, Amy L.
    Odhams, Christopher A.
    Graham, Deborah S. Cunninghame
    Zhang, Xuejun
    Yang, Wanling
    Vyse, Timothy J.
    Morris, David L.
    [J]. HUMAN MOLECULAR GENETICS, 2020, 29 (10) : 1745 - 1756
  • [8] Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4+ T cells
    Chen, S.
    Wang, Y.
    Qin, H.
    Lin, J.
    Xie, L.
    Chen, S.
    Liang, J.
    Xu, J.
    [J]. LUPUS, 2019, 28 (04) : 510 - 519
  • [9] Viruses.STRING: A Virus-Host Protein-Protein Interaction Database
    Cook, Helen Victoria
    Doncheva, Nadezhda Tsankova
    Szklarczyk, Damian
    von Mering, Christian
    Jensen, Lars Juhl
    [J]. VIRUSES-BASEL, 2018, 10 (10):
  • [10] The Immunology of Macrophage Activation Syndrome
    Crayne, Courtney B.
    Albeituni, Sabrin
    Nichols, Kim E.
    Cron, Randy Q.
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10